Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children Source: Eur Respir J 2016; 47: 1152-1161 Year: 2016
The relationship between testosterone, obesity and depressive mood in obstructive sleep apnea (OSA) postmenopausal women Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011
Triglyceride-glucose index in non-diabetic, non-obese patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021
In vitro genioglossus function is different in obese and non-obese patients with obstructive sleep apneaSource: Eur Respir J 2001; 18: Suppl. 33, 332s Year: 2001
Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012
The upper airway and obstructive sleep apnea in morbidly obese women Source: Eur Respir J 2004; 24: Suppl. 48, 119s Year: 2004
Impact of gender on the relationship between obstructive sleep apnoea and hypertension in an otherwise healthy middle-aged sleep clinic cohort Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
The association of obstructive sleep apnea with insulin resistance in obese Egyptians Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008
Obstructive sleep apnea in normal weight patients: characteristics and comparison with overweight and obese patients Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
Gender difference on polysomnographic parameters of severely obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017
Treatment outcomes of obstructive sleep apnoea in obese community-dwelling children: the NANOS study Source: Eur Respir J 2015; 46: 717-727 Year: 2015
Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
The effect of bariatric surgery on sleep apnea and insulin resistance in males and females with severe obesity Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015
Differences in polysomnographic (PSG) parameters between obese and non-obese patients with obstructive sleep apnea (OSA) Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea Year: 2019